Watchlist

Watchlist
Adverum Biotechnologies, Inc. (ADVM)
Adverum Biotechnologies, Inc. (ADVM)
Adverum: Preparing For Liftoff. The Next Abeona
The best risk/reward in Biotech in 2018-19: 30% downside versus 100x upside It is about 12 months since I first recommended Abeona ( ABEO ) as a deep value play in gene therapy and my top pick for 2017. With the stock up 300% since that initial report, it is time to look for 2018's money m…
Adverum Biotechnologies misses by $0.03, beats on revenue
Adverum Biotechnologies (NASDAQ: ADVM ): Q3 EPS of -$0.32 misses by $0.03 . Revenue of $0.46M (+17.9% Y/Y) beats by $0.06M . Press Release More news on: Adverum Biotechnologies, Inc., Earnings news and commentary, Healthcare stocks news, ,
Premarket analyst action - healthcare
Voyager Therapeutics (NASDAQ: VYGR ) initiated with Outperform rating and $35 (46% upside) price target by Raymond James. More news on: Voyager Therapeutics, Spark Therapeutics, REGENXBIO, Healthcare stocks news, Stocks on the move, Read more …
Adverum Biotechnologies (ADVM) Presents At 24th Annual NewsMakers in the Biotech Industry - Slideshow
The following slide deck was published by Adverum Biotechnologies, Inc. in conjunction with this Read more …
How To Value Biotech Firms?
A reader asked me how to learn more about doing valuations of biotech firms. Specifically, pre-revenue biotech firms. Thanks for the impossibly difficult question. Its so tough many investors - perhaps wisely - caution against it. You may have heard the mantra of Buffett to stick t…
Adverum Biotechnologies beats by $0.10, beats on revenue
Adverum Biotechnologies (NASDAQ: ADVM ): Q2 EPS of -$0.27 beats by $0.10 . More news on: Adverum Biotechnologies, Inc., Earnings news and commentary, Healthcare stocks news, , Read more …
After Hours Gainers / Losers
Top gainers, as of 5.25 p.m.: ADVM +2.0% . FMSA +1.9% . TK +1.5% . USLV +1.4% . BGFV +0.8% . More news on: Adverum Biotechnologies, Inc., Fairmount Santrol, Inc., Teekay Corporation, Stocks on the move, News on ETFs, Read more …
Adverum Biotechnologies misses by $0.07, misses on revenue
Adverum Biotechnologies (NASDAQ: ADVM ): Q1 EPS of -$0.38 misses by $0.07 . More news on: Adverum Biotechnologies, Inc., Earnings news and commentary, Healthcare stocks news, , Read more …
Adverum Biotechnologies (ADVM) Presents At Cowen and Company 37th Annual Health Care Conference
The following slide deck was published by Adverum Biotechnologies, Inc. in conjunction with this Read more …
Adverum Biotechnologies misses by $0.24, beats on revenue
Adverum Biotechnologies (NASDAQ: ADVM ): Q4 EPS of -$0.54 misses by $0.24 . Revenue of $0.49M (-49.0% Y/Y) beats by $0.45M . Press Release More news on: Adverum Biotechnologies, Inc., Earnings news and commentary, Healthcare stocks news, ,
Adds and drops from the Nasdaq Biotech Index
Source: Press release More news on: Aimmune Therapeutics, Aralez Pharmaceuticals Inc., AveXis, Healthcare stocks news, News on ETFs, Read more …
Adverum Biotechnologies, Inc. (ADVM)